E. Dale Abel, MD, PhD, is the William S. Adams Distinguished Professor of Medicine, Chair and Executive Medical Director of the Department of Medicine in the David Geffen School of Medicine and UCLA Health.
Dr. Abel’s pioneering work on glucose transport and mitochondrial metabolism in the heart guides his current research interests: molecular mechanisms responsible for cardiovascular complications of diabetes. His laboratory has provided important insights into the contribution of mitochondrial dysfunction and aberrant insulin signaling, to heart failure risk in diabetes. Recent work has focused on mitochondrial mechanisms that mediate inter-organ crosstalk that may influence the pathophysiology of insulin resistance and mitochondrial pathways linking metabolism with increased risk for atherothrombosis.
Dr. Abel, who previously served as ASCI Councilor (2009-12), is the recipient of numerous awards and is an elected member of the National Academy of Sciences, the American Association of Physicians (AAP), the ASCI (profile here), the National Academy of Medicine, and the American Clinical and Climatological Association. He is a past President of the Endocrine Society and is currently President of the Association of Professors of Medicine.
This session will be moderated by Sherita Hill Golden, MD, MHS, the Hugh P. McCormick Family Professor of Endocrinology and Metabolism and Vice President and Chief Diversity Officer for Johns Hopkins Medicine. Dr. Golden is an internationally recognized physician-scientist and member of the AAP, and is Vice Chair of the ASCI Diversity, Equity, and Inclusion Committee.
Tippi Cicek MacKenzie, MD
Fetal therapies for single-gene disorders
The American Society for Clinical Investigation is proud to present the ASCI Scientific Sessions: a monthly spotlight on distinguished investigator...